Perfil
En la actualidad, Russell P. Wilson ocupa el cargo de Vicepresidente Senior de Desarrollo Comercial de Novavax, Inc. Anteriormente ocupó el cargo de Director Financiero y Vicepresidente en Supernus Pharmaceuticals, Inc., Director Financiero, Secretario y Vicepresidente Senior en Intercell USA, Inc. y Consejero General en North American Vaccine, Inc. Obtuvo un MBA y un título de posgrado en la Universidad de Virginia y una licenciatura en la Universidad de Princeton.
Antiguos cargos conocidos de Russell Wilson.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 28/03/2012 |
| IOMAI CORPORATION | Director of Finance/CFO | 01/08/2008 |
North American Vaccine, Inc.
 North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | General Counsel | 01/01/2000 |
| SUPERNUS PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Formación de Russell Wilson.
| University of Virginia | Graduate Degree |
| Princeton University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Health Technology |
Intercell USA, Inc.
 Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Russell Wilson
